Michael J. Kelley, MD | Authors

Autocrine Growth Factors and Neuroendocrine Markers in the Development of Small-Cell Lung Cancer

January 02, 1997

Two different clinical trials using biological agents directed against an autocrine growth factor and a surface marker of neuroendocrine differentiation have been used for patients with relapsed small-cell lung cancer. In a